Fenoldopam is a selective dopamine D₁ receptor agonist used as a rapid-acting antihypertensive agent for the short-term management of severe hypertension and hypertensive emergencies. It produces peripheral vasodilation by activating dopamine D₁ receptors, leading to reduced systemic vascular resistance, improved renal blood flow, and enhanced sodium excretion. Fenoldopam is typically formulated as Fenoldopam Mesylate for intravenous administration in hospital settings.
Mediocon Inc. supplies high-purity Fenoldopam API manufactured under stringent quality management systems. Every batch is subjected to comprehensive analytical testing to ensure compliance with pharmaceutical quality standards for formulation development and commercial manufacturing.
| Parameter | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification | Complies by IR Spectrum, UV and HPLC |
| Assay (HPLC) | ≥99.0% (HPLC) |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.2% |
| Heavy Metals | NMT 10 ppm |
| pH (1% Solution) | 3.5–5.5 |
| Individual Impurity | NMT 0.2% |
| Total Impurities | NMT 1.0% |
| Water Content | NMT 1.0% |
| Specific Rotation | Not Applicable |
| Melting Point | 165–170°C |
| Solubility | Freely soluble in water and methanol; slightly soluble in ethanol |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Fenoldopam API Manufacturer & Supplier in india (CAS 67227-57-0) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Fenoldopam API Manufacturer & Supplier in india is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance